This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
法德藥(4191)宣布，長效抗精神分裂症學名藥Quetiapine Fumarate(150mg,200mg,300mg,400mg ER Tablet)向美國食品藥物管理局(US FDA)提出第四類學名藥(P IV)上市審查申請(遞件)，這也是該公司繼長效型降血壓用藥後的另一P4代表作。
Quetiapine Fumarate ER Tablet是一種長效型抗精神分裂症(Schizophrenia)用藥產品，商品名為Seroquel XR，其原開發廠為阿斯利康製藥(AstraZeneca)。根據2012年的銷售資料顯示，原廠藥在美國市場年銷售額約12億美元，屬年銷10億美元以上的Blockbuster。且這也是法德藥繼2011及2012年成功開發長效型降血壓用藥Metoprolol Succinate ER Tablet產品(商品名：Toprol XL)後，又一成功力作。
法德生技藥品成立於2008年，主要從事特殊學名藥的研究與開發工作，尤其是困難學名藥（Difficult-To-Formulate）及挑戰美國FDA第四類（Paragraph IV, P IV）和首仿（First-To-File）學名藥（Abbreviated New Drug Application, ANDA）的上市申請。
法德藥於2013年12月下旬已接獲美國通路商對長效降血壓藥Metoprolol Succinate ER Tablet產品的訂單，預計今年(2014)接獲FDA最終上市核准函後，產品即同步在美上架銷售，正式邁入營收階段。
有興趣此篇文章的網友，同時也看過下列文章
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
In just a few minutes daily, this course will teach you how to relax and relieve stress. Even with a full schedule, you will want to make time for this!
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
